# A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease

> **NCT02561039** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 97 (actual)

## Conditions studied

- Pain; Bone Neoplasms; Neoplasm Metastasis

## Interventions

- **DRUG:** Ibandronate

## Key facts

- **NCT ID:** NCT02561039
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02561039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02561039, "A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT02561039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*